Employees: 03 (2023.0)Legal category: 5485Size: PMECreation date: 2015-12-08 (10 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CHARLIEU (42190), Loire
Les données financières de cette entreprise sont partiellement disponibles (liasse simplifiée ou données confidentielles). Certaines sections ne sont pas affichées.
SELARL PHARMACIE SAINT PHILIBERT : revenue, balance sheet and financial ratios
SELARL PHARMACIE SAINT PHILIBERT is a French company
founded 10 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CHARLIEU (42190),
this company of category PME
shows in 2024 a net income positive of 52 k€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - SELARL PHARMACIE SAINT PHILIBERT (SIREN 815128335)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
Revenue
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net income
51 962 €
81 993 €
44 236 €
53 443 €
-2 316 €
30 921 €
32 116 €
-1 250 €
EBITDA
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Net margin
N/C
N/C
N/C
N/C
N/C
N/C
N/C
N/C
Revenue and income statement
In 2024, SELARL PHARMACIE SAINT PHILIBERT generates positive net income of 52 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
51 962 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 521%. Critical situation: debt significantly exceeds equity, severely limiting borrowing capacity and exposing the company to default risk. Financial autonomy (= Equity / Total assets x 100) reaches 6%. Low autonomy: the company heavily depends on external financing (banks, suppliers).
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
520.941%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
6.262%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution SELARL PHARMACIE SAINT PHILIBERT
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
1127.416
790.558
475.573
621.26
457.004
355.726
254.45
520.941
Financial autonomy
7.306
9.998
15.632
11.497
14.73
17.783
23.526
6.262
Repayment capacity
None
None
None
None
None
None
None
None
Cash flow / Revenue
None%
None%
None%
None%
None%
None%
None%
None%
Sector positioning
Debt ratio
520.942024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of SELARL PHARMACIE SAINT PH... (520.94) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
6.26%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Watch
In 2024, the financial autonomy of SELARL PHARMACIE SAINT PH... (6.3%) ranks in the bottom 25% of the sector. This ratio represents the share of equity in total financing. Low autonomy may limit investment capacity and increase vulnerability.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 42.36. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
42.357
Liquidity indicators evolution SELARL PHARMACIE SAINT PHILIBERT
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
149.704
157.488
213.273
137.552
140.001
130.445
153.374
42.357
Interest coverage
None
None
None
None
None
None
None
None
Sector positioning
Liquidity ratio
42.362024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch-12 pts over 3 years
In 2024, the liquidity ratio of SELARL PHARMACIE SAINT PH... (42.36) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Positioning of SELARL PHARMACIE SAINT PHILIBERT in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of SELARL PHARMACIE SAINT PHILIBERT is estimated at
725 427 €
(range 505 176€ - 1 085 281€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
505k€725k€1085k€
725 427 €Range: 505 176€ - 1 085 281€
NAF 5 année 2024
Valuation method used
Net Income Multiple
51 962 €
×
14.0x
=725 428 €
Range: 505 177€ - 1 085 282€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare SELARL PHARMACIE SAINT PHILIBERT with other companies in the same sector:
Frequently asked questions about SELARL PHARMACIE SAINT PHILIBERT
What is the revenue of SELARL PHARMACIE SAINT PHILIBERT ?
The revenue of SELARL PHARMACIE SAINT PHILIBERT is not publicly disclosed (confidential accounts filed with INPI).
Is SELARL PHARMACIE SAINT PHILIBERT profitable?
Yes, SELARL PHARMACIE SAINT PHILIBERT generated a net profit of 52 k€ in 2024.
Where is the headquarters of SELARL PHARMACIE SAINT PHILIBERT ?
The headquarters of SELARL PHARMACIE SAINT PHILIBERT is located in CHARLIEU (42190), in the department Loire.
Where to find the tax return of SELARL PHARMACIE SAINT PHILIBERT ?
The tax return of SELARL PHARMACIE SAINT PHILIBERT is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does SELARL PHARMACIE SAINT PHILIBERT operate?
SELARL PHARMACIE SAINT PHILIBERT operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart